Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...

The global preventive healthcare technologies market, valued at $296.48 billion in 2024, is set to hit $1.19 trillion by 2034 ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Dr. Stephana Julia Moss, an investigator at the Canadian Center for Vaccinology (CCfV), Dalhousie University, has been ...

GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and ...

The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key ...

At ASCO 2025, an expert discusses encouraging new early-phase research in clinical trials on treating myeloma.

The stock of Sigachi Industries tanked 6.88 per cent, Shilpa Medicare dropped 4.92 per cent, Suven Life Sciences declined ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

MANILA, Philippines — Watsons Philippines gathered the brilliant names in the health, wellness and beauty industry for its ...

The chronic hepatitis B market size is predicted to surge owing to the increasing prevalence of the disease globally and rising awareness about early diagnosis and treatment. Advances in antiviral ...